WEEKS

Disciplinary Actions against Bradford Weeks, M.D.

In 2007. the Washington Medical Quality Assurance Commission (MQAC) charged Bradford S. Weeks, M.D. with unprofessional conduct for inappropriately prescribing a narcolepsy drug (Xyrem) to eight patients, five of whom he had never seen or examined. In 2008, he signed an agreed order under which he was fined $5,000, prohibited from prescribing Xyrem, required to take an ethics course, and placed on probation for five years. In 2012, Weeks was charged again in connection with his management of four patients. The amended statement of charges, shown below, stated: During 2009, Weeks offered through the Internet an oral spray form of human growth hormone (HGH) as an anti-aging remedy and claimed to prescribe growth hormone to patients to correct “adult growth hormone deficiency syndrome.” Between 2006 …